In T cell acute lymphoblastic leukemia (T-ALL), an aggressive malignancy with a poor prognosis and frequent rates of relapse, mutations in Notch signaling activate the AMPK pathway, which then increases OXPHOS and fuels subsequent leukemia growth [25,26]. This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.